Our results clarify the critical role of Dio3 in local metabolic alterations and propose novel interventions targeting STAT3/Shh/Gli1 signaling aimed at ameliorating tissue-specific metabolic disorders under septic conditions. The gene discussed is SHH; the disease is metabolic disease.